This is a Validated Antibody Database (VAD) review about human NOL3, based on 5 published articles (read how Labome selects the articles), using NOL3 antibody in all methods. It is aimed to help Labome visitors find the most suited NOL3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
NOL3 synonym: ARC; FCM; MYP; NOP; NOP30; nucleolar protein 3; muscle-enriched cytoplasmic protein; nucleolar protein 3 (apoptosis repressor with CARD domain); nucleolar protein of 30 kDa
Santa Cruz Biotechnology
mouse monoclonal (F-11) |
| Santa Cruz Biotechnology NOL3 antibody (Santa Cruz, sc-374177) was used in western blot on rat samples (fig 1a). Redox Biol (2019) ncbi |
Abcam
rabbit polyclonal |
| Abcam NOL3 antibody (Abcam, ab126238) was used in immunocytochemistry on rat samples at 1:200 (fig 5a). Redox Biol (2019) ncbi |
Invitrogen
rabbit polyclonal |
| In order to use a proteomic approach to identify novel proteins associated with human dilated cardiomyopathy, Invitrogen NOL3 antibody (Thermo Scientific, PA1-16860) was used in western blot on human samples at 1:500. J Recept Signal Transduct Res (2013) ncbi |
BD Biosciences
mouse monoclonal (40/Arc) |
| In order to research the role of BDNF-induced LTP in adult hippocampal neurogenesis, BD Biosciences NOL3 antibody (BD Biosciences, 612603) was used in immunohistochemistry on rat samples (fig 2). Sci Rep (2016) ncbi |
mouse monoclonal (40/Arc) |
| In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences NOL3 antibody (BD, 40) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi |
mouse monoclonal (40/Arc) |
| BD Biosciences NOL3 antibody (BD Transduction Laboratories, 612603) was used in western blot on human samples at 1:1000 (fig 7). Sci Rep (2013) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments